What is Carlson Laboratories?
Established in 1965, Carlson Laboratories has evolved from a niche vitamin E provider into a comprehensive manufacturer of over 200 high-quality nutritional supplements. The company is widely recognized for its pioneering role in introducing cod liver oil to the United States market and its commitment to sustainable sourcing, exemplified by the EcoSmart calamari marine oil line. By focusing on purity and clinical efficacy, Carlson Laboratories has successfully navigated decades of market shifts, maintaining a robust distribution network that serves diverse consumer health needs across the globe.
How much funding has Carlson Laboratories raised?
Carlson Laboratories has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Carlson Laboratories
PPP
Public-Private Partnership
What's next for Carlson Laboratories?
With the recent infusion of capital, Carlson Laboratories is well-positioned to accelerate its strategic initiatives, particularly in the areas of supply chain optimization and new product development. As the company moves into this next phase of growth, the focus will likely shift toward expanding its digital footprint and enhancing its manufacturing capabilities to meet the rising demand for premium, natural-source supplements. This financial backing provides the stability required to navigate potential market volatility while continuing to invest in the research and development that has defined the brand for over half a century.
See full Carlson Laboratories company page
